DK409986A - 3-desmethyl-mevalonsyrederivater, fremgangsmaade til fremstillingderaf, pharmaceutiske praeparater paa basis af disse forbindelser, anvendelse deraf samt mellemprodukter - Google Patents

3-desmethyl-mevalonsyrederivater, fremgangsmaade til fremstillingderaf, pharmaceutiske praeparater paa basis af disse forbindelser, anvendelse deraf samt mellemprodukter Download PDF

Info

Publication number
DK409986A
DK409986A DK409986A DK409986A DK409986A DK 409986 A DK409986 A DK 409986A DK 409986 A DK409986 A DK 409986A DK 409986 A DK409986 A DK 409986A DK 409986 A DK409986 A DK 409986A
Authority
DK
Denmark
Prior art keywords
desmethyl
intermediates
procedures
compounds
preparation
Prior art date
Application number
DK409986A
Other languages
English (en)
Other versions
DK409986D0 (da
DK169127B1 (da
Inventor
Gerhard Beck
Bela Kerekjarto
Hans-Hermann Lau
Guenther Wess
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853530797 external-priority patent/DE3530797A1/de
Priority claimed from DE19863615446 external-priority patent/DE3615446A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK409986D0 publication Critical patent/DK409986D0/da
Publication of DK409986A publication Critical patent/DK409986A/da
Application granted granted Critical
Publication of DK169127B1 publication Critical patent/DK169127B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK409986A 1985-08-29 1986-08-28 3-Desmethyl-mevalonsyrederivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende disse forbindelser DK169127B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19853530797 DE3530797A1 (de) 1985-08-29 1985-08-29 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte
DE3530797 1985-08-29
DE19863615446 DE3615446A1 (de) 1986-05-07 1986-05-07 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihrer verwendung sowie zwischenprodukte
DE3615446 1986-05-07

Publications (3)

Publication Number Publication Date
DK409986D0 DK409986D0 (da) 1986-08-28
DK409986A true DK409986A (da) 1987-03-01
DK169127B1 DK169127B1 (da) 1994-08-22

Family

ID=25835463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK409986A DK169127B1 (da) 1985-08-29 1986-08-28 3-Desmethyl-mevalonsyrederivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende disse forbindelser

Country Status (17)

Country Link
US (1) US4914127A (da)
EP (1) EP0217092B1 (da)
JP (1) JPH0830027B2 (da)
KR (1) KR870002114A (da)
AR (1) AR242206A1 (da)
AU (1) AU583943B2 (da)
CA (1) CA1294284C (da)
DE (1) DE3669874D1 (da)
DK (1) DK169127B1 (da)
ES (1) ES2001595A6 (da)
FI (1) FI90868C (da)
GR (1) GR862210B (da)
HU (1) HU195799B (da)
IE (1) IE59312B1 (da)
IL (1) IL79855A0 (da)
NO (1) NO171108C (da)
PT (1) PT83269B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789682A (en) * 1987-03-17 1988-12-06 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3722809A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5470982A (en) * 1988-01-20 1995-11-28 Bayer Aktiengesellschaft Disubstituted pyridines
FR2669031A1 (fr) * 1990-11-09 1992-05-15 Rhone Poulenc Sante Procede de preparation de derives du tetrahydropyranne.
US5840620A (en) * 1994-06-15 1998-11-24 Seager; Carleton H. Method for restoring the resistance of indium oxide semiconductors after heating while in sealed structures
CN101570510B (zh) * 2008-04-30 2011-08-31 上海医药工业研究院 喹啉类化合物及其药物组合物、制备方法和应用
JP5789430B2 (ja) 2011-06-27 2015-10-07 イハラニッケイ化学工業株式会社 2−クロロメチルベンズアルデヒドの製造方法、2−クロロメチルベンズアルデヒド含有組成物及びその保管方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710513A (en) * 1979-08-17 1987-12-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
DE3580863D1 (de) * 1984-06-04 1991-01-24 Merck & Co Inc Herstellungsverfahren von hemmstoffen der hmg-coa-reduktase mit einer 3,5-dihydroxypentanoatteilstruktur.
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4622338A (en) * 1985-03-11 1986-11-11 G. D. Searle & Co. Substituted glutaric acid lactones in the treatment of hyperlipidemia
FR2719387B1 (fr) * 1994-04-28 1996-05-24 Commissariat Energie Atomique Dispositif de contrôle de la position et/ou de la focalisation d'un faisceau lumineux focalisé.

Also Published As

Publication number Publication date
NO171108B (no) 1992-10-19
FI90868B (fi) 1993-12-31
IL79855A0 (en) 1986-11-30
AR242206A1 (es) 1993-03-31
IE59312B1 (en) 1994-02-09
US4914127A (en) 1990-04-03
NO863461L (no) 1987-03-02
ES2001595A6 (es) 1988-06-01
PT83269B (pt) 1989-05-12
KR870002114A (ko) 1987-03-30
PT83269A (de) 1986-09-01
FI863471A0 (fi) 1986-08-27
EP0217092A2 (de) 1987-04-08
GR862210B (en) 1986-12-23
FI863471A (fi) 1987-03-01
FI90868C (fi) 1994-04-11
IE862302L (en) 1987-02-28
NO863461D0 (no) 1986-08-28
DE3669874D1 (de) 1990-05-03
NO171108C (no) 1993-01-27
EP0217092B1 (de) 1990-03-28
HU195799B (en) 1988-07-28
HUT41757A (en) 1987-05-28
DK409986D0 (da) 1986-08-28
AU583943B2 (en) 1989-05-11
JPH0830027B2 (ja) 1996-03-27
JPS6251641A (ja) 1987-03-06
DK169127B1 (da) 1994-08-22
EP0217092A3 (en) 1987-06-16
CA1294284C (en) 1992-01-14
AU6202886A (en) 1987-03-05

Similar Documents

Publication Publication Date Title
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK335686D0 (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK526586A (da) Tetraalkylethenylidenbisphosphonater, fremgangsmaade til fremstilling af disse samt farmaceutisk sammensaetning indeholdende samme
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DK83386D0 (da) Disaccharid- og trisaccharid-derivater af aelipid aae-typen, praeparaterder indeholder disse samt fremgangsmaade til fremstilling af disse
DK165635C (da) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxy-derivater, farmaceutisk praeparat omfattende saadanne forbindelser, samt fremgangsmaade til fremstilling af forbindelserne
DK158505C (da) Fremgangsmaade til fremstilling af roeggasafsvovlingsmiddel, samt anvendelse af produktet til roeggasafsvovling
DK161383C (da) Quinolincarboxylsyre-derivat, fremgangsmaade til fremstilling heraf samt antibakterielle farmaceutiske praeparater indeholdende dette
DK159652C (da) Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK409986A (da) 3-desmethyl-mevalonsyrederivater, fremgangsmaade til fremstillingderaf, pharmaceutiske praeparater paa basis af disse forbindelser, anvendelse deraf samt mellemprodukter
DK66086D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK225382A (da) Substituerede trytaminderivater af thienyloxypropanolaminer fremgangsmaader til fremstilling heraf farmaceutiske praeparater paa basis af disse forbindelser samt deres anvendelse
DK354485A (da) 3-substituerede l-aminoalkyl-lh-indol-forbindelser, fremgangsmaader til fremstilling deraf og mellemprodukter til anvendelse derved samt farmaceutiske praeparater
DK165880C (da) Androstan-17beta-carboxylsyreestere, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende samme
DK161457C (da) Quinolincarboxylsyreforbindelse eller hydrater eller farmaceutisk acceptable salte deraf, fremgangsmaade til deres fremstilling samt antibakterielle farmaceutiske praeparater indeholdende disse
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK191086D0 (da) Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK165553C (da) Imidazolderivater, fremgangsmaade til fremstilling heraf samt anvendelse af disse som fungicider
DK402083A (da) Sulfamoylbenzophenon-derivater, fremgangsmaade til fremstilling deraf, deres anvendelse samt farmaceutiske praeparater paa basis af disse forbindelser
DK163512C (da) Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne
DK240984A (da) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK157007C (da) Vitamin d3 derivater, farmaceutiske praeparater indeholdende disse forbindelser, samt anvendelse af disse forbindelser til fremstilling af farmaceutiske praeparater til behandling af neoplastiske sygdomme eller til induktion af differentiering i maligne celler
DK65986A (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed